Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Chronic Heart Failure

Free Subscription 03.08.2026 2 Am J Cardiol 1 Circ Res 2 Circulation 2 Clin Cardiol 5 Eur J Heart Fail 2 Int J Cardiol 1 J Am Coll Cardiol 4 J Card Fail 2 J Cardiol 2 J Mol Cell Cardiol 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Cardiol

1. NAKAYAMA R, Takaya Y, Nakashima M, Ejiri K, et al
   Association Between Left Atrial Stiffness Index and Clinical Outcomes in Chronic Heart Failure With Impaired Left Ventricular Systolic Function.
   Am J Cardiol. 2026 Jul 25:S0002-9149(26)00474.
   PubMed         Abstract available
   
   
2. JAVAID SS, Hanif M, Paulson S, Anker MS, et al
   GLP-1 Receptor Agonists and Primary Prevention of Cancer Therapy-Related Cardiac Dysfunction.
   Am J Cardiol. 2026;273:59-67.
   PubMed         Abstract available
   
   

   
   Circ Res

3. DAOU D, Das Gupta S, Anand A, May HI, et al
   TFEB Antagonizes Cardiac Hypertrophy and Failure by Enhancing Lysosomal Capacity and Mitochondrial Function.
   Circ Res. 2026;139:e328083.
   PubMed         Abstract available
   
   

   
   Circulation

4. NDUMELE CE, Rodriguez F, Dixon DL, Khan SS, et al
   2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidel
   Circulation. 2026 Jun 9. doi: 10.1161/CIR.0000000000001453.
   PubMed         Abstract available
   
   
5. KHAN SS, Bhave N, Blumenthal RS, Coresh J, et al
   Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Ca
   Circulation. 2026 Jun 9. doi: 10.1161/CIR.0000000000001447.
   PubMed         Abstract available
   
   

   
   Clin Cardiol

6. SAJID EU, Irfan A, Kashan M, Ahmed SR, et al
   Mortality Trend in Patients With Heart Failure and Psychoactive Substance Abuse in the United States-Pre- and Post-COVID-19 Pandemic Perspective (1999-2023).
   Clin Cardiol. 2026;49:e70425.
   PubMed         Abstract available
   
   
7. NADEEM J, Afzal H, Muhammad O, Rizwan A, et al
   Letter to the Editor: Methodological Concerns Regarding "BCR in Heart Failure: When the Abstract Outruns the Evidence".
   Clin Cardiol. 2026;49:e70431.
   PubMed        
   
   

   
   Eur J Heart Fail

8. 
   Correction to: Prevalence, Characteristics and Cardiovascular and Non-Cardiovascular Outcomes in Patients with Heart Failure with Supra-Normal Ejection Fraction: Insight from the JROADHF Study.
   Eur J Heart Fail. 2026 Jul 27:xuag234. doi: 10.1093.
   PubMed        
   
   
9. VERSNJAK J, Kuehne T, Kelm M
   Response to letter regarding 'deep phenotyping of heart failure with preserved ejection fraction through multi-omics integration'.
   Eur J Heart Fail. 2026 Jul 28:xuag225. doi: 10.1093.
   PubMed        
   
   
10. ZURKAN D, Pieske B, Petutschnigg J, Verheyen N, et al
    Spironolactone in the Treatment of Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Design and Baseline Characteristics of the SPIRIT-HF-DZHK08 Trial.
    Eur J Heart Fail. 2026 Jul 28:xuag222. doi: 10.1093.
    PubMed         Abstract available
    
    
11. MOERSDORF M, Verbeeck J, Marrouche NF, Costard-Jaeckle A, et al
    Catheter ablation in end-stage heart failure with atrial fibrillation: an hierarchical endpoint analysis of the CASTLE-HTx trial.
    Eur J Heart Fail. 2026 Jul 30:xuag223. doi: 10.1093.
    PubMed         Abstract available
    
    
12. SOLOVEVA A, Park JJ, Apostolou EA, Bohm M, et al
    Evaluation and management of heart failure patients with liver disease: European Journal of Heart Failure International Expert Position Paper.
    Eur J Heart Fail. 2026 Jul 31:xuag243. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

13. FIORI E, Vanderheyden M, Bartunek J
    Total NT-proBNP in heart failure: Seeing the unseen fraction?
    Int J Cardiol. 2026 Jul 29:134707. doi: 10.1016/j.ijcard.2026.134707.
    PubMed        
    
    
14. BJERREGAARD CL, Sengelov M, Jorgensen PG, Bruun NE, et al
    Association between the E-wave propagation index and left ventricular thrombus formation in systolic heart failure.
    Int J Cardiol. 2026;462:134703.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

15. KHAN MS, Borlaug BA, Butler J, Gomberg-Maitland M, et al
    Pulmonary Hypertension Associated With Left Heart Disease: Challenges, Emerging Strategies, and Future Directions.
    J Am Coll Cardiol. 2026 Mar 11:S0735-1097(26)00134.
    PubMed         Abstract available
    
    

    
    J Card Fail

16. CHAPMAN B, Patolia H, Ryan D, Milinovich A, et al
    The Association of Heart Failure Society of America Optimal Medical Therapy Certification Completion With Sodium Glucose Cotransporter-2 Inhibitor Prescribing.
    J Card Fail. 2026 Jul 15:S1071-9164(26)00366.
    PubMed        
    
    
17. IBE T, Naser JA, Harada T, Tada A, et al
    Clinical Implications of Resting Metabolic Rate in Heart Failure with Preserved Ejection Fraction.
    J Card Fail. 2026 Jul 27:S1071-9164(26)00431.
    PubMed         Abstract available
    
    
18. MIHAI A
    When the Right Ventricle Becomes the Teacher: Lessons from Acute Right Heart Failure.
    J Card Fail. 2026 Jul 27:S1071-9164(26)00429.
    PubMed        
    
    
19. MARQUES P, Matias P, Alves M, Reis C, et al
    Oral iron for the management of iron-deficient anemia in SGLT2i-treated heart failure patients: a prospective study.
    J Card Fail. 2026 Jul 29:S1071-9164(26)00442.
    PubMed        
    
    

    
    J Cardiol

20. WATANABE Y, Kubota Y, Nishino T, Tara S, et al
    Longitudinal changes in renal function after acute heart failure according to worsening renal function and Hemoconcentration status.
    J Cardiol. 2026 Jul 29:S0914-5087(26)00149-8. doi: 10.1016/j.jjcc.2026.
    PubMed         Abstract available
    
    
21. OHNO J, Min KD, Matsumoto Y, Sunayama I, et al
    Ejection fraction-dependent prognostic value of discharge albuminuria in acute decompensated heart failure.
    J Cardiol. 2026 Jul 30:S0914-5087(26)00157-7. doi: 10.1016/j.jjcc.2026.
    PubMed         Abstract available
    
    

    
    J Mol Cell Cardiol

22. KAGAMI K, Nagatomo Y, Toya T, Yumita Y, et al
    Cell-specific ERK2 signaling in vascular smooth muscle cells drives vascular dysfunction and systolic heart failure.
    J Mol Cell Cardiol. 2026 Jul 28:S0022-2828(26)00118.
    PubMed         Abstract available
    
    
23. ZHAO W, Li Q, Chen H, Jiang R, et al
    The Deubiquitinase OTUD5 regulates cardiac hypertrophy by stabilizing TNF receptor associated factor 2.
    J Mol Cell Cardiol. 2026;217:163-175.
    PubMed         Abstract available
    
    

    
    PLoS One

24. NIU C, Xue D, Dong J, Yang Q, et al
    Burden of heart failure in Asian Countries from 1990 to 2021: Update from the Global Burden of Disease Study 2021.
    PLoS One. 2026;21:e0352930.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum